ClinicalTrials.Veeva

Menu

Efficacy of Iodine Complex Against COVID-19 Patients (I-COVID-PK)

S

Sohaib Ashraf

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Corona Virus Infection
Covid19
SARS-CoV-2

Treatments

Drug: Iodine Complex
Drug: Idoine Complex
Drug: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT04473261
SZMC/IRB/Internal/216/2020

Details and patient eligibility

About

The objective of this study is to measure the effect of Iodine complex in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of hospitalization of patients with COVID-19.

Full description

The proposed study is a placebo-controlled, add-on, randomized trial using parallel group designs. This is a close-label and adaptive, multi-centered design with 1:1:1:1 allocation ratio and superiority framework.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Positive PCR with mild to moderate disease

Exclusion criteria

  • Allergic to iodine
  • Any co-morbidity other than hypertension and dietetics

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

200 participants in 4 patient groups, including a placebo group

Iodine Complex (Capsule form)
Experimental group
Description:
Iodine Complex) capsule (200mg) will be given three times a day
Treatment:
Drug: Iodine Complex
Drug: Iodine Complex
Iodine Complex (Syrup form)
Experimental group
Description:
Iodine Complex syrup form (40ml) will be given three times a day
Treatment:
Drug: Iodine Complex
Drug: Iodine Complex
Standard Care Alone
Placebo Comparator group
Description:
Placebo as empty capsule. Treatment will be given for all 4 arms will be receiving standard care as per version 3.0 of clinical management guidelines for COVID-19 established by the Ministry of National Health Services of Pakistan COVID-19 guidelines of the study setting.
Treatment:
Drug: Placebo
Iodine Complex (Nasal Spray)
Experimental group
Description:
Iodine complex throat spray of 2 puffs three times a day.
Treatment:
Drug: Idoine Complex

Trial contacts and locations

1

Loading...

Central trial contact

Shoaib Ashraf, PhD; Sohaib Ashraf, MBBS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems